All Change! Multiple Moves Shake Up US Ranibizumab Market

Biosimilar Rivals To Lucentis Have Enjoyed A Complicated Year

 
• By Dave Wallace
  
Generics Bulletin looks into the US ranibizumab market (Shutterstock)

More from Market Intelligence

More from Generics Bulletin